325 related articles for article (PubMed ID: 26674523)
1. Genetic and Immunohistochemical Expression of Integrins ITGAV, ITGA6, and ITGA3 As Prognostic Factor for Colorectal Cancer: Models for Global and Disease-Free Survival.
Linhares MM; Affonso RJ; Viana Lde S; Silva SR; Denadai MV; de Toledo SR; Matos D
PLoS One; 2015; 10(12):e0144333. PubMed ID: 26674523
[TBL] [Abstract][Full Text] [Related]
2. Relationship between the expression of the extracellular matrix genes SPARC, SPP1, FN1, ITGA5 and ITGAV and clinicopathological parameters of tumor progression and colorectal cancer dissemination.
Viana Lde S; Affonso RJ; Silva SR; Denadai MV; Matos D; Salinas de Souza C; Waisberg J
Oncology; 2013; 84(2):81-91. PubMed ID: 23128103
[TBL] [Abstract][Full Text] [Related]
3. Lack of association between markers in the ITGA3, ITGAV, ITGA6 and ITGB3 and autism in an Irish sample.
Cochrane LE; Tansey KE; Gill M; Gallagher L; Anney RJ
Autism Res; 2010 Dec; 3(6):342-4. PubMed ID: 21182210
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of the ITGAV gene is associated with progression and spread of colorectal cancer.
Waisberg J; De Souza Viana L; Affonso Junior RJ; Silva SR; Denadai MV; Margeotto FB; De Souza CS; Matos D
Anticancer Res; 2014 Oct; 34(10):5599-607. PubMed ID: 25275062
[TBL] [Abstract][Full Text] [Related]
5. Expression and Prognostic Analyses of ITGA3, ITGA5, and ITGA6 in Head and Neck Squamous Cell Carcinoma.
Feng C; Jin X; Han Y; Guo R; Zou J; Li Y; Wang Y
Med Sci Monit; 2020 Oct; 26():e926800. PubMed ID: 33099569
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of integrin αv correlates with poor prognosis in colorectal cancer.
Ha SY; Shin J; Kim JH; Kang MS; Yoo HY; Kim HH; Um SH; Kim SH
J Clin Pathol; 2014 Jul; 67(7):576-81. PubMed ID: 24695839
[TBL] [Abstract][Full Text] [Related]
7. The role of MUC1 and MUC3 in the biology and prognosis of colorectal cancer.
Duncan TJ; Watson NF; Al-Attar AH; Scholefield JH; Durrant LG
World J Surg Oncol; 2007 Mar; 5():31. PubMed ID: 17349047
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.
Iinuma H; Watanabe T; Mimori K; Adachi M; Hayashi N; Tamura J; Matsuda K; Fukushima R; Okinaga K; Sasako M; Mori M
J Clin Oncol; 2011 Apr; 29(12):1547-55. PubMed ID: 21422427
[TBL] [Abstract][Full Text] [Related]
9. ITGA3 and ITGB4 expression biomarkers estimate the risks of locoregional and hematogenous dissemination of oral squamous cell carcinoma.
Nagata M; Noman AA; Suzuki K; Kurita H; Ohnishi M; Ohyama T; Kitamura N; Kobayashi T; Uematsu K; Takahashi K; Kodama N; Kawase T; Hoshina H; Ikeda N; Shingaki S; Takagi R
BMC Cancer; 2013 Sep; 13():410. PubMed ID: 24006899
[TBL] [Abstract][Full Text] [Related]
10. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
Song A; Eo W; Lee S
World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of spondin-2 predicts poor survival of colorectal carcinoma patients.
Zhang Q; Wang XQ; Wang J; Cui SJ; Lou XM; Yan B; Qiao J; Jiang YH; Zhang LJ; Yang PY; Liu F
Oncotarget; 2015 Jun; 6(17):15095-110. PubMed ID: 25945835
[TBL] [Abstract][Full Text] [Related]
12. Serine threonine tyrosine kinase 1 is a potential prognostic marker in colorectal cancer.
Hu L; Chen HY; Cai J; Zhang Y; Qi CY; Gong H; Zhai YX; Fu H; Yang GZ; Gao CF
BMC Cancer; 2015 Apr; 15():246. PubMed ID: 25884558
[TBL] [Abstract][Full Text] [Related]
13. A scoring model for predicting survival following primary tumour resection in stage IV colorectal cancer patients with unresectable metastasis.
Dorajoo SR; Tan WJ; Koo SX; Tan WS; Chew MH; Tang CL; Wee HL; Yap CW
Int J Colorectal Dis; 2016 Feb; 31(2):235-45. PubMed ID: 26490055
[TBL] [Abstract][Full Text] [Related]
14. Spalt-like transcription factor 4 as a potential diagnostic and prognostic marker of colorectal cancer.
Wu HK; Liu C; Fan XX; Wang H; Zhou L
Cancer Biomark; 2017 Aug; 20(2):191-198. PubMed ID: 28869451
[TBL] [Abstract][Full Text] [Related]
15. High expression of PFTK1 in cancer cells predicts poor prognosis in colorectal cancer.
Mao Y; Jia Y; Zhu H; Wang W; Jin Q; Huang F; Zhang S; Li X
Mol Med Rep; 2017 Jul; 16(1):224-230. PubMed ID: 28498444
[TBL] [Abstract][Full Text] [Related]
16. ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis.
Agesen TH; Sveen A; Merok MA; Lind GE; Nesbakken A; Skotheim RI; Lothe RA
Gut; 2012 Nov; 61(11):1560-7. PubMed ID: 22213796
[TBL] [Abstract][Full Text] [Related]
17. Identification of a metastasis-specific MicroRNA signature in human colorectal cancer.
Hur K; Toiyama Y; Schetter AJ; Okugawa Y; Harris CC; Boland CR; Goel A
J Natl Cancer Inst; 2015 Mar; 107(3):. PubMed ID: 25663689
[TBL] [Abstract][Full Text] [Related]
18. Lack of Caudal-Type Homeobox Transcription Factor 2 Expression as a Prognostic Biomarker in Metastatic Colorectal Cancer.
Zhang BY; Jones JC; Briggler AM; Hubbard JM; Kipp BR; Sargent DJ; Dixon JG; Grothey A
Clin Colorectal Cancer; 2017 Jun; 16(2):124-128. PubMed ID: 27726953
[TBL] [Abstract][Full Text] [Related]
19. Low expression of RASSF10 is associated with poor survival in patients with colorectal cancer.
Wang F; Li P; Feng Y; Hu YL; Liu YF; Guo YB; Jiang XL; Mao QS; Xue WJ
Hum Pathol; 2017 Apr; 62():108-114. PubMed ID: 28041974
[TBL] [Abstract][Full Text] [Related]
20. Identification and Clinical Validation of a Novel 4 Gene-Signature with Prognostic Utility in Colorectal Cancer.
Ahluwalia P; Mondal AK; Bloomer C; Fulzele S; Jones K; Ananth S; Gahlay GK; Heneidi S; Rojiani AM; Kota V; Kolhe R
Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31387239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
